335 related articles for article (PubMed ID: 16361132)
21. [Development of fluorescent in vivo imaging probes for cancers].
Tanaka S; Kizaka-Kondoh S
Gan To Kagaku Ryoho; 2008 Aug; 35(8):1272-6. PubMed ID: 18701836
[TBL] [Abstract][Full Text] [Related]
22. Whole-body magnetic resonance imaging and positron emission tomography-computed tomography in oncology.
Schmidt GP; Kramer H; Reiser MF; Glaser C
Top Magn Reson Imaging; 2007 Jun; 18(3):193-202. PubMed ID: 17762383
[TBL] [Abstract][Full Text] [Related]
23. Is hybridic positron emission tomography/computerized tomography the only option? The future of nuclear medicine and molecular imaging.
Grammaticos P; Zerva C; Asteriadis I; Trontzos C; Hatziioannou K
Hell J Nucl Med; 2007; 10(2):74-6. PubMed ID: 17684579
[TBL] [Abstract][Full Text] [Related]
24. From molecular imaging in preclinical/clinical oncology to theranostic applications in targeted tumor therapy.
Alberti C
Eur Rev Med Pharmacol Sci; 2012 Dec; 16(14):1925-33. PubMed ID: 23242718
[TBL] [Abstract][Full Text] [Related]
25. The progress and promise of molecular imaging probes in oncologic drug development.
Kelloff GJ; Krohn KA; Larson SM; Weissleder R; Mankoff DA; Hoffman JM; Link JM; Guyton KZ; Eckelman WC; Scher HI; O'Shaughnessy J; Cheson BD; Sigman CC; Tatum JL; Mills GQ; Sullivan DC; Woodcock J
Clin Cancer Res; 2005 Nov; 11(22):7967-85. PubMed ID: 16299226
[TBL] [Abstract][Full Text] [Related]
26. Molecular imaging with bioconjugates in mouse models of cancer.
Mather S
Bioconjug Chem; 2009 Apr; 20(4):631-43. PubMed ID: 19086866
[TBL] [Abstract][Full Text] [Related]
27. Molecular-genetic imaging based on reporter gene expression.
Kang JH; Chung JK
J Nucl Med; 2008 Jun; 49 Suppl 2():164S-79S. PubMed ID: 18523072
[TBL] [Abstract][Full Text] [Related]
28. [Oncological imaging].
Herold C; Reiser MF; Graser A
Radiologe; 2013 Apr; 53(4):302. PubMed ID: 23549860
[No Abstract] [Full Text] [Related]
29. Therapy Monitoring with Functional and Molecular MR Imaging.
García-Figueiras R; Padhani AR; Baleato-González S
Magn Reson Imaging Clin N Am; 2016 Feb; 24(1):261-288. PubMed ID: 26613885
[TBL] [Abstract][Full Text] [Related]
30. Imaging response assessment in oncology.
Curran SD; Muellner AU; Schwartz LH
Cancer Imaging; 2006 Oct; 6(Spec No A):S126-30. PubMed ID: 17114065
[TBL] [Abstract][Full Text] [Related]
31. Pediatric oncology and the future of oncological imaging.
Voss SD
Pediatr Radiol; 2011 May; 41 Suppl 1():S172-85. PubMed ID: 21523594
[TBL] [Abstract][Full Text] [Related]
32. Challenges and opportunities for in vivo imaging in oncology.
Sullivan DC
Technol Cancer Res Treat; 2002 Dec; 1(6):419-22. PubMed ID: 12625769
[TBL] [Abstract][Full Text] [Related]
33. Nuclear medicine imaging of endocrine neoplasms.
Wong KK; Kandathil A; Marzola MC; Gross MD; Rubello D
Nucl Med Commun; 2014 Jan; 35(1):1-19. PubMed ID: 24201551
[TBL] [Abstract][Full Text] [Related]
34. Molecular imaging in cancer.
Weissleder R
Science; 2006 May; 312(5777):1168-71. PubMed ID: 16728630
[TBL] [Abstract][Full Text] [Related]
35. If you can't see it, you can miss it: the role of biomedical imaging in radiation oncology.
Schlegel W
Radiat Prot Dosimetry; 2010; 139(1-3):321-6. PubMed ID: 20223847
[TBL] [Abstract][Full Text] [Related]
36. Magnetic resonance in the era of molecular imaging of cancer.
Gore JC; Manning HC; Quarles CC; Waddell KW; Yankeelov TE
Magn Reson Imaging; 2011 Jun; 29(5):587-600. PubMed ID: 21524870
[TBL] [Abstract][Full Text] [Related]
37. Oncologic imaging: a guiding hand of personalized cancer care.
Hricak H
Radiology; 2011 Jun; 259(3):633-40. PubMed ID: 21493796
[No Abstract] [Full Text] [Related]
38. Transcriptomics in cancer diagnostics: developments in technology, clinical research and commercialization.
Sager M; Yeat NC; Pajaro-Van der Stadt S; Lin C; Ren Q; Lin J
Expert Rev Mol Diagn; 2015; 15(12):1589-603. PubMed ID: 26565429
[TBL] [Abstract][Full Text] [Related]
39. Optical imaging in oncology.
Kim HL
Urol Oncol; 2009; 27(3):298-300. PubMed ID: 19414116
[TBL] [Abstract][Full Text] [Related]
40. Noninvasive imaging of tumor burden and molecular pathways in mouse models of cancer.
Wang Y; Tseng JC; Sun Y; Beck AH; Kung AL
Cold Spring Harb Protoc; 2015 Feb; 2015(2):135-44. PubMed ID: 25646505
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
